TG-101209

Alias: TG 101209; TG-101209; TG101209
Cat No.:V0050 Purity: ≥98%
TG101209 is a novel, potent, orally bioactive and selective small molecule JAK2 inhibitor with IC50 of 6 nM.
TG-101209 Chemical Structure CAS No.: 936091-14-4
Product category: c-RET
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
5mg
10mg
25mg
50mg
100mg
250mg
Other Sizes
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text

 

  • Business Relationship with 5000+ Clients Globally
  • Major Universities, Research Institutions, Biotech & Pharma
  • Citations by Top Journals: Nature, Cell, Science, etc.
Top Publications Citing lnvivochem Products
Purity & Quality Control Documentation

Purity: ≥98%

Product Description

TG101209 is a novel, potent, orally bioactive and selective small molecule JAK2 inhibitor with IC50 of 6 nM. TG101209 has an IC50 of 6 nM. It is about 30 times more selective for JAK2 than JAK3 and is sensitive to the JAK2V617F and MPLW515L/K mutations. It is less potent to Flt3 and RET with IC50 values of 25 nM and 17 nM in cell-free assays. In numerous multiple myeloma (MM) cell lines, it caused cytotoxicity that was dose- and time-dependent. TG101209 exhibits anticancer properties.

Biological Activity I Assay Protocols (From Reference)
Targets
JAK2 (IC50 = 6 nM); JAK3 (IC50 = 169 nM); RET (IC50 = 17 nM); FLT3 (IC50 = 25 nM)
ln Vitro
TG101209 is an orally bioavailable, small molecule, ATP-competitive inhibitor towards several tyrosine kinases. TG101209 has an IC50 of 200 nM and inhibits the growth of Ba/F3 cells expressing JAK2V617F or MPLW515L mutations. TG101209 induces cell cycle arrest and apoptosis in a human acute myeloid leukemia cell line expressing JAK2V617F, and it prevents JAK2V617F, STAT5 and STAT3 from being phosphorylated. Primary progenitor cells with JAK2V617F or MPL515 mutations grow hematopoietic colonies less quickly when TG101209 is present.[1] Without changing the total amount of STAT5 protein, TG101209 significantly lowers STAT5 phosphorylation. [2] In HCC2429 and H460 lung cancer cells, TG101209 inhibits survivin and lowers the phosphorylation of STAT3. Lung cancer cells HCC2429 and H460 become radiosensitive in vitro when exposed to TG101209.[3] According to a recent study, TG101209 suppresses BCR-JAK2 and STAT5 phosphorylation, lowers Bcl-xL expression, and induces apoptosis in transformed Ba/F3 cells.[4]
ln Vivo
In a JAK2V617F-induced disease, 100 mg/kg of TG101209 significantly extends survival (10 days). Statistically significant, dose-dependent reductions in the circulating tumor cell burden of up to 20% are seen in TG101209-treated animals at day +11 compared to animals that received a placebo. [1]
Enzyme Assay
IC50 values for TG101209 are determined using a luminescence-based kinase assay with recombinant JAK2, VEGFR2/KDR, and JAK3 obtained from Upstate Cell Signaling Solutions. Kinase reactions are conducted in a buffer containing 40 mM Tris buffer (pH 7.4), 50 mM MgCl2, 800 mM EGTA, 350 mM Triton X-100, 2 mM -mercaptoethanol, 100 mM peptide substrate, and an adequate concentration of JAK2, VEGFR2/KDR, or JAK3 to ensure that the assay is linear over 60 minutes. After 60 minutes, Kinase-Glo reagent is added to end the reaction, which was started by the addition of 10 L of ATP to a 3 mM final concentration. An Ultra 384 instrument set for luminosity measurements is used to measure luciferase activity.
Cell Assay
In brief, the indicated TG101209 concentrations are added to 100 ml of RPMI-1640 growth media, and 2 × 103 cells are plated into microtiterplate wells. Using the Cell Proliferation Kit II (XTT) in accordance with the manufacturer's instructions, the relative growth of cells is measured every 24 hours. 4-6 hours of incubation follow the addition of 20 mL of XTT to the wells. With correction at 650 nm, the colored formazan product is measured spectrophotometrically at 450 nm, and IC50 values are calculated using the GraphPad Prism 4.0 program. The concentration (IC50) that inhibited proliferation by 50% was found after the data were subjected to a non-linear regression-fit analysis. The results of each experiment are normalized to the growth of untreated cells and performed in triplicate.
Animal Protocol
The GFP-positive BaF/3 cells expressing JAK2V617F (Ba/F3-V617F-GFP) are sorted and administered intravenously to SCID mice (severe combined immunodeficiency). On day +3 following the infusion of tumor cells and continuing until day +20, TG101209 is given by oral gavage at the indicated doses. On day +11 after tumor cell injection, 1 mL of blood is taken by terminal cardiac bleeding from the mouse that receives the vehicle, and 0.1 mL of blood is taken by non-lethal retro-orbital collection from each of the three groups of six mice that received doses of 10, 30, or 100 mg/kg (twice daily) of TG101209, with samples combining within the dose groups. With 600 RCF and 30 minutes of centrifugation, blood mononuclear cells are separated using the Ficoll cushion technique. FACS analysis is used to calculate the proportion of GFP-positive tumor cells in the isolated cells(that is, Ba/F3-V617F-GFP cells).
References

[1]. Leukemia . 2007 Aug;21(8):1658-68.

[2]. Exp Hematol . 2009 Dec;37(12):1379-1386.e4.

[3]. J Thorac Oncol . 2011 Apr;6(4):699-706.

[4]. PLoS One . 2012;7(2):e32451.

[5]. Blood . 2009 Dec 3;114(24):5024-33.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C26H35N7O2S
Molecular Weight
509.67
Exact Mass
509.25729
Elemental Analysis
C, 61.27; H, 6.92; N, 19.24; O, 6.28; S, 6.29
CAS #
936091-14-4
Appearance
white solid powder
SMILES
CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)N4CCN(CC4)C
InChi Key
JVDOKQYTTYUYDV-UHFFFAOYSA-N
InChi Code
InChI=1S/C26H35N7O2S/c1-19-18-27-25(29-20-9-11-22(12-10-20)33-15-13-32(5)14-16-33)30-24(19)28-21-7-6-8-23(17-21)36(34,35)31-26(2,3)4/h6-12,17-18,31H,13-16H2,1-5H3,(H2,27,28,29,30)
Chemical Name
N-tert-butyl-3-[[5-methyl-2-[4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide
Synonyms
TG 101209; TG-101209; TG101209
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO: ~102 mg/mL (~200.1 mM)
Water: <1 mg/mL (slightly soluble or insoluble)
Ethanol: <1 mg/mL (slightly soluble or insoluble)
Solubility (In Vivo)
1%DMSO+30% polyethylene glycol+1%Tween 80: 12mg/mL
 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 1.9621 mL 9.8103 mL 19.6205 mL
5 mM 0.3924 mL 1.9621 mL 3.9241 mL
10 mM 0.1962 mL 0.9810 mL 1.9621 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Biological Data
  • TG101209

    Mechanism of action of TG101209. Am J Hematol. 2010 Sep;85(9):675-86.
  • TG101209

    Preferential killing of CD45+ cells by TG101209. Am J Hematol. 2010 Sep;85(9):675-86.
  • TG101209

    TG101209 synergizes with PI3K inhibitor LY294002 in killing myeloma cells. Am J Hematol. 2010 Sep;85(9):675-86.
Contact Us